INS and Hyperglycemia: Among many therapeutic approaches like gluconeogenesis inhibition, insulin injection, and increasing the number of glucose transporters to manage hyperglycemia (Forouhi et al., 2018), reduction in gastrointestinal glucose production and absorption through inhibition of carbohydrate hydrolyzing enzymes could be considered as a potent recourse.